Catalent Pharma Solutions
   HOME

TheInfoList



OR:

Catalent, Inc. (Catalent Pharma Solutions), is an American multinational company, and a subsidiary of
Novo Holdings A/S Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novonesis (formerly ''Novozymes A/S''). Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundat ...
since 2024. It is headquartered in
Somerset, New Jersey Somerset is an unincorporated community and census-designated place (CDP) located within Franklin Township, in Somerset County, in the U.S. state of New Jersey.
. It is a provider of drug delivery technologies,
drug development Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regu ...
,
drug manufacturing Pharmaceutical manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs as part of the pharmaceutical industry. The process of drug manufacturing can be broken down into a series of unit operations, such as milling M ...
,
biologics A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, th ...
,
gene therapy Gene therapy is Health technology, medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or through altering the biological properties of living cells. The first attempt at modifying human DNA ...
, and consumer health products. It has over 50 facilities on four continents and has supported more than half the products approved by the
Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respo ...
in the last ten years. Annually, it produces 70 billion doses for 8,000 products. The company's major customers include
Bayer Bayer AG (English: , commonly pronounced ; ) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer' ...
,
Bristol-Myers Squibb The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consist ...
,
GlaxoSmithKline GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British Multinational corporation, multinational Pharmaceutics, pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a Mergers an ...
,
Haleon Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil pa ...
,
Novo Nordisk Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S ...
,
Moderna Moderna, Inc. ( ) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry inst ...
,
Pfizer Pfizer Inc. ( ) is an American Multinational corporation, multinational Pharmaceutical industry, pharmaceutical and biotechnology corporation headquartered at The Spiral (New York City), The Spiral in Manhattan, New York City. Founded in 184 ...
, and
Sarepta Therapeutics Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, , archiveurl = http://www.gene-tools.co ...
.


History


Before 2007

In 1996,
Cardinal Health Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals ...
acquired PCI of
Philadelphia, Pennsylvania Philadelphia ( ), colloquially referred to as Philly, is the List of municipalities in Pennsylvania, most populous city in the U.S. state of Pennsylvania and the List of United States cities by population, sixth-most populous city in the Unit ...
, a pharmaceutical contract packing service for commercial and clinical packaging. In 1998, Cardinal Health acquired R.P. Scherer Corporation of
Troy, Michigan Troy is a city in Oakland County, Michigan, Oakland County in the U.S. state of Michigan. A northern suburb of Metro Detroit, Detroit, Troy is located about north of downtown Detroit. As of the 2020 census, the city had a population of 87,294, ...
for $2.2 billion; it was founded by
Robert Pauli Scherer Robert Pauli Scherer (1906–1960) was an American inventor who founded the RP Sherer Corporation. In 1933, Scherer invented the rotary die encapsulation process, revolutionizing the soft-gelatin encapsulation field. He founded the R. P. Sch ...
to commercialize his innovation of
softgel A softgel is an oral dosage form for medicine in the form of a specialized capsule. They consist of a shell, usually gelatin based, surrounding a liquid fill. Softgel shells are a combination of gelatin, water, opacifier and a plasticiser such ...
encapsulation using the rotary die production process. In 1999, Cardinal Health acquired Automatic Liquid Packaging of
Woodstock, Illinois Woodstock is a city in and the county seat of McHenry County, Illinois, McHenry County, Illinois, United States. It is located 51 miles northwest of Chicago, making it one of the city's outer-most suburbs. Per the 2020 United States census, 2020 ...
, thereby entering the sterile product market with
blow fill seal Blow-Fill-Seal, also spelled as Blow/Fill/Seal, in this article abbreviated as BFS, is an automated manufacturing process by which plastic containers, such as bottles or ampoules are, in a continuous operation, blow-formed, filled, and sealed. It ...
technology. In January 2001, Cardinal Health acquired International Processing Corporation, a company that was renowned for its expertise in oral
modified-release dosage Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release R, XR, XLdosage) or to a spe ...
form development and manufacturing, for $40 million. In April 2002, Cardinal Health acquired Magellan Laboratories, a company that specialized in product development expertise. In October 2003, Cardinal Health acquired Gala Biotech of
Madison, Wisconsin Madison is the List of capitals in the United States, capital city of the U.S. state of Wisconsin. It is the List of municipalities in Wisconsin by population, second-most populous city in the state, with a population of 269,840 at the 2020 Uni ...
for $15.5 million. It also acquired Intercare Group of the UK for $530 million, broadening its global capabilities in Europe.


2007–2019

In April 2007, the pharmaceutical technologies and services segment of Cardinal Health was acquired by affiliates of
The Blackstone Group Blackstone Inc. is an American alternative investment management company based in New York City. It was founded in 1985 as a mergers and acquisitions firm by Peter G. Peterson, Peter Peterson and Stephen A. Schwarzman, Stephen Schwarzman, who h ...
and re-branded as Catalent Pharma Solutions. In February 2012, Catalent acquired Aptuit, a clinical supply company. As part of the deal, Catalent gained three sites in the US, two in the UK, and one in Singapore. Catalent also acquired all remaining shares for the R.P Scherer site in Eberbach, Germany. In March 2013, Catalent continued the global expansion of its Softgel capabilities through a joint venture with Zhejiang Jaing Yuan Tang Biotechnology, a China-based company, and Relthy Laboratories in Brazil. In July 2014, Catalent became a
public company A public company is a company whose ownership is organized via shares of share capital, stock which are intended to be freely traded on a stock exchange or in over-the-counter (finance), over-the-counter markets. A public (publicly traded) co ...
via an
initial public offering An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investm ...
on the New York Stock Exchange, raising $870 million. In November 2014, Catalent acquired Micron Technologies, a provider of particle size engineering technologies, expanding its portfolio of drug delivery technologies. In September 2016, Catalent acquired Pharmatek Laboratories to add spray drying capabilities. In October 2016, Catalent licensed the anti-body drug conjugate (ADC) to Triphase Accelerator to help with
oncology Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an ''oncologist''. The name's Etymology, etymological origin is the Greek word ὄγ ...
development, In September 2017, Catalent agreed to acquire Cook Pharmica for $950 million, expanding its biologic manufacturing. In July 2018, Catalent acquired Juniper Pharmaceuticals for $133 million. In March 2019, Catalent invested more than $27 million to commercialize Zydis Ultra. The investment includes new Zydis lines; changes to facilities in
Swindon Swindon () is a town in Wiltshire, England. At the time of the 2021 Census the population of the built-up area was 183,638, making it the largest settlement in the county. Located at the northeastern edge of the South West England region, Swi ...
, UK; and a custom suite for commercial equipment. In September 2018, Catalent partnered with GB Sciences to develop a cannabinoid-derived medicine for
Parkinson's disease Parkinson's disease (PD), or simply Parkinson's, is a neurodegenerative disease primarily of the central nervous system, affecting both motor system, motor and non-motor systems. Symptoms typically develop gradually and non-motor issues become ...
utilizing the Zydis delivery method. In May 2019, Catalent acquired Paragon Bioservices for $1.2 billion to expand its gene-therapy manufacturing capabilities. By October 2019, Paragon's employee count doubled since the April acquisition.


2020–present

In January 2020, Catalent purchased a manufacturing facility located in
Anagni Anagni () is an ancient town and ''comune'' in the province of Frosinone, Lazio, in the hills east-southeast of Rome. It is a historical and artistic centre of the Latin Valley. Geography Overview Anagni still maintains the appearance of a s ...
, Italy, from
Bristol-Myers Squibb The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consist ...
, to manufacture and package biologic and oral solid dose products for multiple companies. In February 2020, Catalent agreed to acquire MaSTherCell, a Belgian gene and cell therapy manufacturer, for $315 million, to expand into cell therapy development. In 2020, Catalent partnered with multiple drugmakers, including
Pfizer Pfizer Inc. ( ) is an American Multinational corporation, multinational Pharmaceutical industry, pharmaceutical and biotechnology corporation headquartered at The Spiral (New York City), The Spiral in Manhattan, New York City. Founded in 184 ...
,
Johnson & Johnson Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a c ...
,
AstraZeneca AstraZeneca plc () (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas includi ...
, and
Moderna Moderna, Inc. ( ) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry inst ...
to provide manufacturing, vial filling and packaging capabilities for
COVID-19 vaccine A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 ( COVID19). Knowledge about the structure and fun ...
s. In the partnership with AstraZeneca, Catalent provided manufacturing from its Maryland facility and vial filling and packaging from its Italian facility. Catalent also partnered with ViralClear to manufacture a COVID-19 treatment candidate at Catalent's facility in
St. Petersburg, Florida St. Petersburg is a city in Pinellas County, Florida, United States. As of the 2020 census, the population was 258,308, making it the List of municipalities in Florida, fifth-most populous city in Florida and the most populous city in the sta ...
. In August 2021, Catalent acquired German gene therapy development firm Rheincell Therapeutics. That month, Catalent also acquired Bettera Holdings, a nutritional supplement company, for $1 billion to provide capability to manufacture vitamins, minerals and supplements in gummy form. In October 2021, Catalent opened a 6,000 square-meter clinical supply facility in
Shiga, Japan is a landlocked prefecture of Japan in the Kansai region of Honshu. Shiga Prefecture has a population of 1,398,972 as of 1 February 2025 and has a geographic area of . Shiga Prefecture borders Fukui Prefecture to the north, Gifu Prefecture to th ...
. In August 2022, the company acquired Metrics Contract Services, a
contract manufacturing organization A contract manufacturing organization (CMO), more recently referred to (and more commonly used now) as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organ ...
, for $475 million. In October 2022, Catalent announced a $12M expansion at a
Kansas City, Missouri Kansas City, Missouri, abbreviated KC or KCMO, is the largest city in the U.S. state of Missouri by List of cities in Missouri, population and area. The city lies within Jackson County, Missouri, Jackson, Clay County, Missouri, Clay, and Pl ...
facility. In January 2023, Catalent partnered with
Sarepta Therapeutics Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, , archiveurl = http://www.gene-tools.co ...
to manufacture
delandistrogene moxeparvovec Delandistrogene moxeparvovec, sold under the brand name Elevidys, is a recombinant gene therapy used for the treatment of Duchenne muscular dystrophy. It is designed to deliver into the body a gene that leads to production of Elevidys micro-dy ...
(SRP-9001). Sarepta's most advanced
gene therapy Gene therapy is Health technology, medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or through altering the biological properties of living cells. The first attempt at modifying human DNA ...
candidate for the treatment of
Duchenne muscular dystrophy Duchenne muscular dystrophy (DMD) is a severe type of muscular dystrophy predominantly affecting boys. The onset of muscle weakness typically begins around age four, with rapid progression. Initially, muscle loss occurs in the thighs and pe ...
(DMD). In December 2024,
Novo Holdings A/S Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novonesis (formerly ''Novozymes A/S''). Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundat ...
acquired Catalent for $16.5billion. As part of the transaction,
Novo Nordisk Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S ...
acquired three manufacturing facilities from parent Novo Holdings for $11billion to scale up production to meet the demand of Wegovy and
Ozempic Semaglutide is an anti-diabetic medication used for the treatment of type2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a s ...
.


Financials


References


External links

* {{Authority control 2014 initial public offerings 2024 mergers and acquisitions American subsidiaries of foreign companies Biotechnology companies of the United States Companies based in Somerset County, New Jersey Companies formerly listed on the New York Stock Exchange Drug discovery companies Gene therapy Life sciences industry Pharmaceutical companies based in New Jersey Pharmaceutical companies established in 2007 Contract development and manufacturing organizations